Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Y Lui

Showing results (261-270 of 294) with videos related to

Pageof 30
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 5, 2006
Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinomaC-Y Hsia, T-I Huo, S-Y Chiang, et al.
Cancer Chemotherapy and Pharmacology|April 3, 2013
Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinomaStephen L Chan, Chi-Hang Wong, Cecilia P Y Lau, et al.
World Journal of Surgery|April 29, 2000
Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinomaY H Huang, J C Wu, W Y Lui, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Transcatheter arterial chemoembolization for hepatocellular carcinomaC F Yang, Y Z Ho, J M Chang, et al.
Hepatology (Baltimore, Md.)|November 1, 1986
Monoclonal antibodies against antigens expressed on human hepatocellular carcinoma cellsC P Hu, S H Han, W Y Lui, et al.
FEBS Letters|December 16, 2014
miR-466 is putative negative regulator of Coxsackie virus and Adenovirus ReceptorW Y Lam, Ariel C Y Cheung, Christine K C Tung, et al.
Investigational New Drugs|May 28, 2009
The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell linesBrigette B Y Ma, Vivian W Y Lui, Edwin P Hui, et al.
British Journal of Cancer|July 14, 1998
Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patientsY Chao, W K Chan, M J Birkhofer, et al.
BMC Cancer|November 14, 2018
Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinomaLiyong Zhang, Zhihong Li, Yehai Liu, et al.
Head & Neck|February 11, 2010
Induction of laryngeal cancer cell death by Ent-11-hydroxy-15-oxo-kaur-16-en-19-oic acidAlexander C Vlantis, Chun Shan Lo, George G Chen, et al.
Pageof 30

Showing results (261-270 of 294) with videos related to

Sort By:
Pageof 30
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 5, 2006
Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinomaC-Y Hsia, T-I Huo, S-Y Chiang, et al.
Cancer Chemotherapy and Pharmacology|April 3, 2013
Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinomaStephen L Chan, Chi-Hang Wong, Cecilia P Y Lau, et al.
World Journal of Surgery|April 29, 2000
Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinomaY H Huang, J C Wu, W Y Lui, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Transcatheter arterial chemoembolization for hepatocellular carcinomaC F Yang, Y Z Ho, J M Chang, et al.
Hepatology (Baltimore, Md.)|November 1, 1986
Monoclonal antibodies against antigens expressed on human hepatocellular carcinoma cellsC P Hu, S H Han, W Y Lui, et al.
FEBS Letters|December 16, 2014
miR-466 is putative negative regulator of Coxsackie virus and Adenovirus ReceptorW Y Lam, Ariel C Y Cheung, Christine K C Tung, et al.
Investigational New Drugs|May 28, 2009
The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell linesBrigette B Y Ma, Vivian W Y Lui, Edwin P Hui, et al.
British Journal of Cancer|July 14, 1998
Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patientsY Chao, W K Chan, M J Birkhofer, et al.
BMC Cancer|November 14, 2018
Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinomaLiyong Zhang, Zhihong Li, Yehai Liu, et al.
Head & Neck|February 11, 2010
Induction of laryngeal cancer cell death by Ent-11-hydroxy-15-oxo-kaur-16-en-19-oic acidAlexander C Vlantis, Chun Shan Lo, George G Chen, et al.
Pageof 30